Background and aims As a curative procedure, hematopoietic stemcell transplantation
(HSCT) is an approved treatment for many malignant orbenign hematologic and non …

Multiple myeloma (MM) is the main indication for autologous stem cell transplantation
(ASCT). Novel supportive therapies (eg, granulocyte colony-stimulating factor) have …

Data about biosimilar Peg-filgrastim (bioPEG) in autologous stem cell transplant (ASCT) are
still scarce. The aim of this study has been to assess efficacy and safety of bioPEG among …

Objectives: To assess local epidemiology and risk factors for bacterial, fungal, and viral
infections among the autologous bone marrow transplant population. Methods: This study is …

Recent studies demonstrated that myeloid-derived suppressor cells (MDSCs) are involved
in the pathogenesis and progression of multiple myeloma (MM). Nevertheless, data on the …

Background Treatment with high-dose chemotherapy and stem cell transplantation has
prolonged survival in patients of multiple myeloma (MM). A dose-response relationship …

Purpose To analyze the factors affecting the mobilization efficiency of hematopoietic stem
cells and hematopoietic reconstruction indicators during autologous peripheral …

Autologous stem cell transplantation (ASCT) is the standard treatment for many high-risk
solid tumors. Patients undergoing ASCT should be managed in a dedicated hematopoietic …

Introduction: Lymphoma is a diverse group of malignant proliferations that arise as discrete
tissue masses. The 5th edition of the World Health Organization classification of Tumours of …

Introducción El Trasplante Autólogo de Progenitores Hematopoyeticos de Sangre Periferica
(TAPHSP) es una opción terapéutica la cual puede ser utilizado en varias neoplasias de la …